216 related articles for article (PubMed ID: 29016855)
1. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.
Woo JA; Liu T; Zhao X; Trotter C; Yrigoin K; Cazzaro S; Narvaez E; Khan H; Witas R; Bukhari A; Makati K; Wang X; Dickey C; Kang DE
Hum Mol Genet; 2017 Oct; 26(20):3973-3988. PubMed ID: 29016855
[TBL] [Abstract][Full Text] [Related]
2. RanBP9 at the intersection between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 reduction.
Woo JA; Boggess T; Uhlar C; Wang X; Khan H; Cappos G; Joly-Amado A; De Narvaez E; Majid S; Minamide LS; Bamburg JR; Morgan D; Weeber E; Kang DE
Cell Death Dis; 2015 Mar; 6(3):1676. PubMed ID: 25741591
[TBL] [Abstract][Full Text] [Related]
3. Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration.
Woo JA; Jung AR; Lakshmana MK; Bedrossian A; Lim Y; Bu JH; Park SA; Koo EH; Mook-Jung I; Kang DE
Cell Death Differ; 2012 Sep; 19(9):1413-23. PubMed ID: 22361682
[TBL] [Abstract][Full Text] [Related]
4. COPS5 (Jab1) protein increases β site processing of amyloid precursor protein and amyloid β peptide generation by stabilizing RanBP9 protein levels.
Wang H; Dey D; Carrera I; Minond D; Bianchi E; Xu S; Lakshmana MK
J Biol Chem; 2013 Sep; 288(37):26668-77. PubMed ID: 23926111
[TBL] [Abstract][Full Text] [Related]
5. Cooperative role of RanBP9 and P73 in mitochondria-mediated apoptosis.
Liu T; Roh SE; Woo JA; Ryu H; Kang DE
Cell Death Dis; 2013 Jan; 4(1):e476. PubMed ID: 23348590
[TBL] [Abstract][Full Text] [Related]
6. RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease.
Wang R; Palavicini JP; Wang H; Maiti P; Bianchi E; Xu S; Lloyd BN; Dawson-Scully K; Kang DE; Lakshmana MK
Neurobiol Dis; 2014 Sep; 69():169-79. PubMed ID: 24892886
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role of RanBP9 in integrin-dependent focal adhesion signaling and assembly.
Woo JA; Roh SE; Lakshmana MK; Kang DE
FASEB J; 2012 Apr; 26(4):1672-81. PubMed ID: 22223749
[TBL] [Abstract][Full Text] [Related]
8. A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid-beta peptide generation.
Lakshmana MK; Chung JY; Wickramarachchi S; Tak E; Bianchi E; Koo EH; Kang DE
FASEB J; 2010 Jan; 24(1):119-27. PubMed ID: 19729516
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway.
Roh SE; Woo JA; Lakshmana MK; Uhlar C; Ankala V; Boggess T; Liu T; Hong YH; Mook-Jung I; Kim SJ; Kang DE
FASEB J; 2013 Dec; 27(12):4776-89. PubMed ID: 23982146
[TBL] [Abstract][Full Text] [Related]
10. RanBP9 overexpression reduces dendritic arbor and spine density.
Wang H; Lewsadder M; Dorn E; Xu S; Lakshmana MK
Neuroscience; 2014 Apr; 265():253-62. PubMed ID: 24486966
[TBL] [Abstract][Full Text] [Related]
11. Novel role of RanBP9 in BACE1 processing of amyloid precursor protein and amyloid beta peptide generation.
Lakshmana MK; Yoon IS; Chen E; Bianchi E; Koo EH; Kang DE
J Biol Chem; 2009 May; 284(18):11863-72. PubMed ID: 19251705
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 activator Aha1 drives production of pathological tau aggregates.
Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
[TBL] [Abstract][Full Text] [Related]
13. RanBP9 overexpression down-regulates phospho-cofilin, causes early synaptic deficits and impaired learning, and accelerates accumulation of amyloid plaques in the mouse brain.
Palavicini JP; Wang H; Minond D; Bianchi E; Xu S; Lakshmana MK
J Alzheimers Dis; 2014; 39(4):727-40. PubMed ID: 24254706
[TBL] [Abstract][Full Text] [Related]
14. RanBP9 overexpression accelerates loss of pre and postsynaptic proteins in the APΔE9 transgenic mouse brain.
Wang H; Wang R; Xu S; Lakshmana MK
PLoS One; 2014; 9(1):e85484. PubMed ID: 24454876
[TBL] [Abstract][Full Text] [Related]
15. RanBP9 aggravates synaptic damage in the mouse brain and is inversely correlated to spinophilin levels in Alzheimer's brain synaptosomes.
Palavicini JP; Wang H; Bianchi E; Xu S; Rao JS; Kang DE; Lakshmana MK
Cell Death Dis; 2013 Jun; 4(6):e667. PubMed ID: 23764848
[TBL] [Abstract][Full Text] [Related]
16. BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.
Elliott E; Tsvetkov P; Ginzburg I
J Biol Chem; 2007 Dec; 282(51):37276-84. PubMed ID: 17954934
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of Hsp70 family variants fosters tau accumulation.
Jinwal UK; Akoury E; Abisambra JF; O'Leary JC; Thompson AD; Blair LJ; Jin Y; Bacon J; Nordhues BA; Cockman M; Zhang J; Li P; Zhang B; Borysov S; Uversky VN; Biernat J; Mandelkow E; Gestwicki JE; Zweckstetter M; Dickey CA
FASEB J; 2013 Apr; 27(4):1450-9. PubMed ID: 23271055
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears Amyloid-β and Tau in a Mouse Model of Alzheimer's Disease.
Lee S; Choi BR; Kim J; LaFerla FM; Park JHY; Han JS; Lee KW; Kim J
Mol Nutr Food Res; 2018 Jun; 62(12):e1800240. PubMed ID: 29714053
[TBL] [Abstract][Full Text] [Related]
19. Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.
Zhang T; Xia Y; Hu L; Chen D; Gan CL; Wang L; Mei Y; Lan G; Shui X; Tian Y; Li R; Zhang M; Lee TH
Int J Biol Sci; 2022; 18(2):693-706. PubMed ID: 35002518
[TBL] [Abstract][Full Text] [Related]
20. Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.
Fontaine SN; Rauch JN; Nordhues BA; Assimon VA; Stothert AR; Jinwal UK; Sabbagh JJ; Chang L; Stevens SM; Zuiderweg ER; Gestwicki JE; Dickey CA
J Biol Chem; 2015 May; 290(21):13115-27. PubMed ID: 25864199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
